Wolverine Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.83M | Buy |
|
|||||
|
2025
Q1 | $1.59M | Buy |
|
|||||
|
2024
Q4 | $1.59M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $203K | Sell |
|
|||||
|
2023
Q4 | $2.79M | Sell |
|
|||||
|
2023
Q3 | $4.02M | Buy |
|
|||||
|
2023
Q2 | $3.19M | Sell |
|
|||||
|
2023
Q1 | $4.27M | Buy |
|
|||||
|
2022
Q4 | $3.84M | Buy |
|
|||||
|
2022
Q3 | $2.94M | Buy |
|
|||||
|
2022
Q2 | $2.18M | Buy |
|
|||||
|
2022
Q1 | $407K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $46K | Sell |
|
|||||
|
2020
Q1 | $4.58M | Sell |
|
|||||
|
2019
Q4 | $5.88M | Buy |
|
|||||
|
2019
Q3 | $3.3M | Buy |
|
|||||
|
2019
Q2 | $2.94M | Sell |
|
|||||
|
2019
Q1 | $3.12M | Buy |
|
|||||
|
2018
Q4 | $2.09M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.13M | Buy |
|
|||||
|
2018
Q1 | $1.07M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $398K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $239K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $483K | Buy |
|